Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001677687-18-000001
Filing Date
2018-12-11
Accepted
2018-12-11 12:53:58
Documents
1
Period of Report
2018-12-06

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 3146
  Complete submission text file 0001677687-18-000001.txt   4584
Mailing Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042
Business Address 2500 WILCREST DRIVE, 3RD FLOOR HOUSTON TX 77042 832-781-8521
AngioSoma, Inc. (Issuer) CIK: 0001502152 (see all company filings)

EIN.: 273480481 | State of Incorp.: NV | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations

Mailing Address 14001 WALDEN RD. SUITE 600 MONTGOMERY TX 77356
Business Address
Blankenship Alex K (Reporting) CIK: 0001677687 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-55072 | Film No.: 181228281